Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
SNSE
SNSE
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
SNSE News
Biotech Investment Revives as Institutional Capital Flows Back
Mar 19 2026
Globenewswire
Sensei Biotherapeutics Grants Stock Options to New Employee
Mar 17 2026
Newsfilter
Sensei Biotherapeutics Grants Stock Options to New Employees
Feb 25 2026
Newsfilter
Sensei Biotherapeutics Secures $200 Million Financing and Acquires Faeth
Feb 18 2026
stocktwits
U.S. Stocks Rise, Nasdaq Gains Over 1%
Feb 18 2026
Benzinga
Sensei Biotherapeutics Acquires Faeth Therapeutics for $200M
Feb 18 2026
seekingalpha
U.S. Stocks Rise in Morning Trading, Dow Up Approximately 100 Points
Feb 18 2026
Benzinga
Biotech Stocks Surge: Coherus Up 9.09% in After-Hours Trading
Jan 23 2026
NASDAQ.COM
What Caused Sensei Biotherapeutics (SNSE) Stock to Surge Nearly 63% in After-Hours Trading?
Dec 05 2025
Benzinga
Healthcare and Biotech Stocks Surge in After-Hours Trading: Sensei, Praxis, Cooper, Vanda, Cue, ResMed
Dec 05 2025
NASDAQ.COM
Sensei Biotherapeutics Launches Strategic Review Aimed at Enhancing Shareholder Value
Oct 30 2025
Newsfilter
Post-Market Jump: Turn Therapeutics Soars 134% Following Nasdaq Debut; Biotech Stocks Rise
Oct 09 2025
NASDAQ.COM
HC Wainwright & Co. Maintains Buy on Sensei Biotherapeutics, Raises Price Target to $30
Aug 05 2025
Benzinga
Sensei Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Aug 05 2025
Newsfilter
Sensei Biotherapeutics to Present Clinical Data from the Phase 1 Dose Expansion Cohort of Solnerstotug at the ESMO Congress 2025
Jul 30 2025
Newsfilter
Upcoming Stock Splits This Week (June 16 to June 20) – Stay Invested
Jun 15 2025
TipRanks
Show More News
